17.07.2013 Views

View Annual Report - Jules Stein Eye Institute

View Annual Report - Jules Stein Eye Institute

View Annual Report - Jules Stein Eye Institute

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Genetics of Age-Related<br />

Maculopathy (GARM II)<br />

The purpose of this study is to identify<br />

the hereditary and exposure risk factors<br />

that lead to the development of<br />

age-related maculopathy (ARM) in<br />

a cohort with a family history of the<br />

disease. The study is intended for<br />

individuals (49 and older) who have<br />

at least one parent with this condition,<br />

the spouses or partners of these<br />

individuals, and the parents themselves.<br />

Investigators: Michael B. Gorin, MD,<br />

PhD; and Maria Carolina Ortube, MD<br />

Heavy Metals in Surgically<br />

Removed Human Ocular Tissue<br />

Faculty members are examining the<br />

concentration of heavy metals in ocular<br />

tissue compared to blood concentrations.<br />

High volumes of specific heavy<br />

metals in the vitreous have been found<br />

to cause toxicity in the retina. Information<br />

about the concentrations of<br />

heavy metals in common vitreoretinal<br />

diseases could lead to a new physiopathological<br />

approach. Investigators:<br />

Jean-Pierre Hubschman, MD; and<br />

Steven D. Schwartz, MD<br />

Incidence of Late Macular<br />

Degeneration in Older Women<br />

The goal of this research is to determine<br />

the incidence of late age-related<br />

macular degeneration (AMD), the<br />

rate of progression of AMD, and the<br />

association of specific risk factors such<br />

as diabetes mellitus and prior cataract<br />

surgery with late AMD and its progression<br />

in older women. Investigator: Anne<br />

L. Coleman, MD, PhD<br />

Investigational Drug for Treatment<br />

of Vascular Pigment Epithelial<br />

Detachment (vPED)<br />

The purpose of this study is to see if<br />

the treatment of a vPED, a complication<br />

of macular degeneration, with<br />

ranibizumab is safe and effective<br />

with the regular dose (0.5 mg) or<br />

the high dose (2.0 mg). Investigators:<br />

David Sarraf, MD; and Colin A.<br />

McCannel, MD<br />

Natural History Study of<br />

Macular Telangiectasia<br />

Investigators are collecting data about<br />

macular telangiectasia with the goal<br />

of acquiring more knowledge of and<br />

developing a treatment for this rare<br />

retinal disease. Investigators: Steven<br />

D. Schwartz, MD; Michael B. Gorin, MD,<br />

PhD; Jean-Pierre Hubschman, MD;<br />

Allan E. Kreiger, MD; Tara A. McCannel,<br />

MD, PhD; and David Sarraf, MD<br />

Ocular Hazards from Currently<br />

Available Light Curing Units<br />

The purpose of this study is to assess<br />

the potential of currently available<br />

curing lights to cause retinal damage<br />

to dental personnel, to evaluate the<br />

amount of exposure to curing lights by<br />

dental personnel, and to assess current<br />

levels of retinal degenerative changes<br />

in dental workers that are possibly<br />

induced by curing lights. Investigators:<br />

Jean-Pierre Hubschman, MD; and<br />

Steven D. Schwartz, MD<br />

P200CAF Autofluorescence<br />

Ultra-Widefield Scanning Laser<br />

Ophthalmoscope in Subjects<br />

with Vitreoretinal Disease<br />

This study utilizes an ultra-widefield<br />

scanning laser ophthalmoscope with<br />

autofluorescence (SLO-AF) to take<br />

pictures of the retina in a noninvasive<br />

way. Images acquired with the SLO-AF<br />

are compared with those from other<br />

currently available instruments to evaluate<br />

the potentially improved resolution<br />

for diagnosis of retinal eye diseases.<br />

Investigators: Steven D. Schwartz, MD;<br />

Jean-Pierre Hubschman, MD; Allan<br />

E. Kreiger, MD; and Tara A. McCannel,<br />

MD, PhD<br />

Pars Plana Vitrectomy with and<br />

without ILM Peel<br />

This study is evaluating and comparing<br />

possible differences in the vision, as<br />

well as the thickness and shape of the<br />

back of the eye, following pars plana<br />

vitrectomy surgery with and without<br />

internal limiting membrane peeling in<br />

patients with complications of diabetic<br />

retinopathy. Investigator: Jean-Pierre<br />

Hubschman, MD<br />

Rapid, Noninvasive, Regional<br />

Functional Imaging of the Retina<br />

In this study funded by the NIH,<br />

<strong>Institute</strong> investigators are monitoring<br />

the responses of the pupil to light as a<br />

method for detecting regional losses<br />

of function of the retina. The ultimate<br />

goal of this research is to develop a<br />

simple, noninvasive, rapid method for<br />

widespread screening of diabetics in<br />

order to identify those who may require<br />

medical attention and/or therapy for<br />

diabetic retinopathy. Investigators:<br />

Michael B. Gorin, MD, PhD; and Maria<br />

Carolina Ortube, MD<br />

Resolution of Vitreomacular<br />

Adhesion Associated with<br />

Neovascular Age-Related<br />

Macular Degeneration with<br />

Intravitreal Microplasmin<br />

Faculty members are evaluating the<br />

safety and efficacy of intravitreal injection<br />

of microplasmin on age-related<br />

macular degeneration (AMD) with<br />

focal vitreomacular adhesion (VMA).<br />

Previous research has shown that<br />

intravitreal microplasmin may offer<br />

physicians a safe agent for resolution<br />

of focal VMA in AMD patients<br />

without surgery. Investigators: Steven<br />

D. Schwartz, MD; and Jean-Pierre<br />

Hubschman, MD<br />

Understanding the Genetics of<br />

Inherited <strong>Eye</strong> Disorders<br />

The <strong>Institute</strong> is participating in a study<br />

to search for the gene(s) responsible<br />

for inherited disorders that are either<br />

specific to the eye or have eye findings<br />

as part of the medical condition. This<br />

study provides for the clinical characterization<br />

of affected individuals and<br />

at-risk family members, in conjunction<br />

with molecular genetic testing, to identify<br />

the causative genes and mutations.<br />

Investigators: Anthony J. Aldave, MD;<br />

Michael B. Gorin, MD, PhD; and Maria<br />

Carolina Ortube, MD<br />

Appendices | Clinical Research Studies 109

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!